In preparation:

WALTON M, POWERS J, HOBART J, PATRICK D, MARQUIS P, VAMVAKAS S, ISAAC M,  PAPADOPOULOS E, SLAGE A, PIAULT E, BURKE L. Clinical Outcome Assessments for Clinical Therapy Trials:   Conceptual Underpinnings

POWERS J, HOBART J, BURKE L, PATRICK D, MARQUIS P, WALTON M, VAMVAKAS S, ISAAC M,  PAPADOPOULOS E, SLAGE A, PIAULT E. Using Clinician-Reported Outcome Measures to Assess Treatment Benefit: Good Measurement Principles.


MARQUIS P, DELGADO-HERRERA L, KOTHARI S, et al. Development of a Patient-Reported Outcome Symptom Measure in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)


MARQUIS P, CARON M, EMERY M-P, et al. (2011). The Role of Health-Related Quality of Life Data in the Drug Approval Processes in the US and Europe: A Review of Guidance Documents and Authorizations of Medicinal Products from 2006 to 2010. Pharm Med 2011; 25 (3): 147–60.

LASCH K, MARQUIS P, VIGNEUX M, et al. PRO development: rigorous qualitative research as the crucial foundation. Qual Life Res. 2010 October; 19(8): 1087–1096.

MARQUIS P, ARNOULD B, ACQUADRO C, et al. Patient-Reported Outcomes and Health-Related Quality of Life in effectiveness studies: pros and cons.  Drug Development Research 2006; 67:193-201

DIBENEDETTI DB, GONDEK K, SAGNIER PP, KUBIN M, MARQUIS P, KEININGER D et al. The treatment satisfaction scale: a multidimensional instrument for the assessment of treatment satisfaction for erectile dysfunction patients and their partners. Eur Urol 2005; 48(3):503-511.

HASLE-PHAM E, ARNOULD B, SPATH H, FOLLET A, DURU G, MARQUIS P. Role of clinical, patient-reported outcome and medio-economic studies in the public hospital drug formulary decision-making process: results of a European survey. Health Policy 2005; 71:205-212.

MARQUIS P, DE LA LOGE C, DUBOIS D, McDERMOTT A, CHASSANY O. Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire. Scand J Gastroenterol 2005; 40(5):540-551.

ACQUADRO C, BERZON R, DUBOIS D, LEIDY N, MARQUIS P, REVICKI D et al. Incorporating the patient’s perspective into drug development and commuciation: An Ad Hoc Task Force Report of the Patient-Reported Outcomes (PRO) Harmonization Group Meeting at the Food and Drug Administration, February 16, 2001. Value in Health 2004; 6(5):522-531.

DE LA LOGE C, TRUDEAU E, MARQUIS P, REVICKI D, RENTZ A, STANGHELLINI V et al. Responsiveness and Interpretation of a Quality of Life Questionnaire Specific to Upper Gastrointestinal Disorders. Clinical Gastroenterology and Hepatology 2004; 2:778-786.

DE LA LOGE C, TRUDEAU E, MARQUIS P, Kahrilas P, Stanghellini V, Talley NJ et al. Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res 2004; 13(10):1751-1762.

EVANS C, TRUDEAU E, MERTZANIS P, MARQUIS P, PENA B, WONG J et al. Development and validation of the pain treatment satisfaction scale: (ptss): a patient satisfaction questionnaire for use in patients with chronic or acute pain. International Association for the Study of Pain 2004; 112:254-266.

MARQUIS P, CHASSANY O, ABETZ L. A comprehensive strategy for the interpretation of quality-of-life data based on existing methods. Value in Health 2004; 7(1):93-04.

MARQUIS P, MARREL A, JAMBON B. Quality of life in patients with stomas: the montreux study. OstomyWound Management 2003; 49(2):48-55.

CHASSANY O, SAGNIER P, MARQUIS P, FULLERTON S, AARONSON N, ERIQA Group. Patient-reported outcomes: the example of health-related quality of life – A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal 2002; 36:209-238.

LAMPING DL, SCHROTER S, MARQUIS P, MARREL A, DUPRAT-LOMON I, SAGNIER PP. The Community-Acquired Pneumonia Symptom Questionnaire – A new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia. Chest 2002; 122:920-929.

SYMONDS T, BERZON R, MARQUIS P, RUMMANS TA, and the Clinical Significance Consensus Meeting Group. The clinical significance of quality of life results: practical considerations for specific audiences. Mayo Clinic Proceedings 2002; 77:572-583.

BLONDEL-KUCHARSKI F, CHIRCOP C, MARQUIS P, CORTOT A, BARON F, GENDRE JP et al. Health-related quality of life in Crohn’s disease: a prospective longitudinal study in 231 patients. The American Journal of Gastroenterology 2001; 96(10):2915-2920.

COLVEZ A, COSTA P, DIDIER JP, ESPIRAC B, LERICHE B, MARQUIS P et al. Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of Qualiveen. European Urology 2001; 39:107-113.

JAMBON B, MARQUIS P, BURKE L, KIND P, KLINE LEIDY N, BAROFSKY I et al. A decisive step towards the recognition of patient reported outcomes in clinical trials. Quality of Life Newsletter 2001; 26:24-25.

MARQUIS P, MARREL A. Reproducibility and clinical and concurrent validity of the MSF-4: a four-item male sexual function questionnaire for patients with benign prostatic hyperplasia. Value Health 2001; 4(4):335-343.

MARQUIS P, TRUDEAU E. Quality of life and patient satisfaction: two important aspects in asthma therapy. Current Opinion in Pulmonary Medicine 2001; 7(S1):S18-S20.

MARQUIS P, LE GAL M, FRANCILLON A, ANDRE-FOUET X. Quality of life in angina pectoris. Comparison of the effects of two discontinuous nitrate treatments: transdermal 10 mg nitroglycerine patch (12 hours) and long-acting oral 40 mg isosorbide-5-mononitrate (once a day).  [In French] Qualité de vie et angine de poitrine. Comparaison des effets de deux dérivés nitrés administrés de façon discontinue : trinitrine 10 mg, 12 heures, par voie transdermique, et isosorbide-5-mononitrate à libération prolongée 40 mg, monoprise, par voie orale. Ann Cardiol Agéiol 2001; 50:340-350.

MARQUIS P, CIALDELLA P, DE LA LOGE C. Development and validation of a specific quality of life module in post-menopausal women with osteoporosis: the QUALIOST TM. Quality of Life Research 2001; 10:555-566.

MARQUIS P, COMTE S, LEHERT P. International validation of the CLAU-S Quality of Life Questionnaire for use in patients with intermittent claudication. PharmacoEconomics 2001; 19(6):667-677.

WOOL C, CERUTTI R, MARQUIS P, CIALDELLA P, HERVIE C, ITALIAN STUDY GROUP ON QUALITY OF LIFE (ISGQL). Psychometric validation of two Italian quality of life questionnaires in menopausal women. Maturitas 2000; 35:129-142.

CHASSANY O, MARQUIS P, SCHERRER B, READ NW, FINGER T, BERGMANN JF et al. Validation of a Specific Quality of Life Questionnaire for Functional Digestive Disorders. Gut 1999; 44(4):527-533.

ENCK P, DUBOIS D, MARQUIS P. Quality of life in patients with upper gastrointestinal symptoms: results from the domestic/international gastroenterology surveillance study (DIGEST). Scandinavian Journal of Gastroenterology 1999; 34(Suppl. 231):48-54.

PATRICK D, MARTIN ML, BUSHNELL DM, MARQUIS P. Cultural adaptation of a quality-of-life measure for urinary incontinence. European Urology 1999; 36:427-435.

BERDEAUX G, HERVIE C, SMAJDA C, MARQUIS P. Parental quality of life and recurrent ENT infections in their children: development of a questionnaire. Quality of Life Research 1998; 7(6):501-512.


Book Chapters

MARQUIS P, KEININGER D, ACQUADRO C, DE LA LOGE C. Translating and evaluating questionnaires: cultural issues for international research. In: FAYERS P, HAYS R, editors. Assessing Quality of Life in Clinical Trials. New York: Oxford University Press, 2005: 77-93.

MARQUIS P. Quality of life assessment in neurogenic bladder. In: CORCOS J, SCHICK E, editors. Textbook of Neurogenic Bladder: Adults and Children. London: Martin Dunitz Ltd, 2004: 365-372.

MARQUIS P, LADEMACHER C, ROZENBAUM H. Once a week transdermal estrogen -quality of life improvement in long-term replacement therapy: newest findings. In: PAOLETTI R, CROSIGNAMI PG, ENEMANS P, ENGER NK, ACKSON AS, editors. Women’s Health and Menopause: Risk Reduction Strategies -Improved Quality of Health. Kluwer Academic Publishers, 1999: 183-188.

AMARENCO G, MARQUIS P, JACQUETIN B, RICHARD F. Evaluation de la perturbation de la qualité de vie au cours des hyperactivités vésicales. Evaluation de l’hyperactivité. Paris: Elsevier, 1998: 61-66.

ACQUADRO C, JAMBON B, ELLIS D, MARQUIS P. Language and Translation Issues. In: SPILKER B, editor. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven Publishers, 1996: 575-585.

Copyright © 2014 TwoLegs Consulting LLC, All Rights Reserved.